Expertise: No Longer a Sine Qua Non for Guideline Authors?

Franz H Messerli¹, Louis Hofstetter², Enrico Agabiti-Rosei²+27

• ¹From the Department of Cardiology and Clinical Research, Inselspital Bern, University of Bern, Switzerland (F.H.M., L.H., S.F.R.); Mount Sinai Icahn School of Medicine, New York, NY (F.H.M.); Jagiellonian University Krakow, Poland (F.H.M.); Department of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, Italy (E.A.R.); Service de Néphrologie et Hypertension, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland (M.B.); Department of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, WA (W.J.E.); Heart Disease Prevention Program, Division of Cardiology, Department of Medicine, C240 Medical Sciences, University of California, Irvine (S.S.F.); Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland (T.G.); Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan (K.K.); Department of Cardiology, University of Oslo, Ullevaal Hospital, Norway (S.E.K.); Cardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.B.K.); Departments of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, University Paris Descartes, France (S.L.); Hypertension Unit, University of Ottawa Heart Institute, ON, Canada (F.H.L.); Department of Heart Diseases, University of Bergen, Haukeland Hospital, Norway (P.L.-J.); University of Milano-Bicocca, IRCCS Istituto Auxologico Italiano, Italy (G.M.); Department of Hypertension and Diabetology, Medical University of Gdansk, Poland (K.N.); Hypertension and Cardiovascular Research Clinic, Veterans Affairs and Georgetown University Medical Centers, Washington DC (V.P.); Department of Cardiovascular, Neural and Metabolic Sciences, Ospedale S. Luca IRCCS Istituto Auxologico Italiano, Milan; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy (G.P.); Imperial Clinical Trials Unit, Imperial College London, United Kingdom (N.P.); Hospital Clinico Unviersitario de Valencia, Spain (J.R.); Department of Nephrology, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain (L.M.R.); Lady Davis Institute for Medical Research and Department of Medicine, Jewish General Hospital, McGill University, Montreal, QC, Canada (E.L.S.); Department of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Germany (R.E.S.); Division of Nephrology and Hypertension, Department of Medicine, and American Society of Hypertension, Drexel University College of Medicine, Philadelphia, PA (A.B.S.); International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London-Hammersmith Campus, United Kingdom (P.S.); Diabetes and Cardiovascular Center, University of Missouri School of Medicine, Columbia; Research Service, Harry S. Truman Memorial Veterans Hospital, Research Service, Columbia; Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia (J.R.S.); University of Leuven, Belgium (J.A.S.); Department of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (J.W.); SUNY Downstate Medical Center, Brooklyn, NY (M.W.); and University College London and NIHR University College London Hospitals Biomedical Research Centre, University College London, UK (B.W.). messerli.f@gmail.com.+1